DK1156795T3 - Anvendelse af ravsyre eller salte deraf, og fremgangsmåde til behandling af insulinresistens - Google Patents
Anvendelse af ravsyre eller salte deraf, og fremgangsmåde til behandling af insulinresistensInfo
- Publication number
- DK1156795T3 DK1156795T3 DK99933301T DK99933301T DK1156795T3 DK 1156795 T3 DK1156795 T3 DK 1156795T3 DK 99933301 T DK99933301 T DK 99933301T DK 99933301 T DK99933301 T DK 99933301T DK 1156795 T3 DK1156795 T3 DK 1156795T3
- Authority
- DK
- Denmark
- Prior art keywords
- methods
- succinic acid
- insulin resistance
- salts
- treating insulin
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Diabetes (AREA)
- Epidemiology (AREA)
- Endocrinology (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Emergency Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Peptides Or Proteins (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/RU1999/000055 WO2000051594A1 (en) | 1999-03-01 | 1999-03-01 | Use of succinic acid or salts thereof and method of treating insulin resistance |
EP99933301A EP1156795B1 (de) | 1999-03-01 | 1999-03-01 | Verwendung von bernsteisäure oder deren salze zur behandlung von insulinresistenz |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1156795T3 true DK1156795T3 (da) | 2004-11-01 |
Family
ID=20130328
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK99933301T DK1156795T3 (da) | 1999-03-01 | 1999-03-01 | Anvendelse af ravsyre eller salte deraf, og fremgangsmåde til behandling af insulinresistens |
Country Status (10)
Country | Link |
---|---|
US (1) | US6521665B1 (de) |
EP (1) | EP1156795B1 (de) |
AT (1) | ATE268170T1 (de) |
AU (1) | AU4937499A (de) |
CA (1) | CA2366073A1 (de) |
DE (1) | DE69917809T2 (de) |
DK (1) | DK1156795T3 (de) |
ES (1) | ES2222717T3 (de) |
PT (1) | PT1156795E (de) |
WO (1) | WO2000051594A1 (de) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001076583A1 (en) * | 2000-04-10 | 2001-10-18 | Verteletsky, Pavel Vasilievich | Synergistic compositions containing choline base and succinic acid for insulin resistance and diabetes |
CN101815515A (zh) * | 2007-08-02 | 2010-08-25 | 布达生物制药有限公司 | 含有琥珀酸的鼻内用药物组合物 |
US20120107850A1 (en) * | 2009-07-15 | 2012-05-03 | Panasonic Corporation | Analysis reagent and analysis device having the analysis reagent carried therein |
JP5460183B2 (ja) * | 2009-08-28 | 2014-04-02 | パナソニック株式会社 | 分析用試薬および分析用デバイス |
KR20210024056A (ko) * | 2018-06-22 | 2021-03-04 | 엔진 바이오사이언스 리미티드 | 혈액 장애 치료를 위한 숙신산 및 유도체 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS61171417A (ja) * | 1985-01-23 | 1986-08-02 | Wakunaga Seiyaku Kk | 抗糖尿病剤 |
JP3581157B2 (ja) | 1992-08-19 | 2004-10-27 | 株式会社ミツカングループ本社 | 低耐糖能者用食品 |
-
1999
- 1999-03-01 WO PCT/RU1999/000055 patent/WO2000051594A1/en active IP Right Grant
- 1999-03-01 AT AT99933301T patent/ATE268170T1/de not_active IP Right Cessation
- 1999-03-01 ES ES99933301T patent/ES2222717T3/es not_active Expired - Lifetime
- 1999-03-01 AU AU49374/99A patent/AU4937499A/en not_active Abandoned
- 1999-03-01 CA CA002366073A patent/CA2366073A1/en not_active Abandoned
- 1999-03-01 DK DK99933301T patent/DK1156795T3/da active
- 1999-03-01 DE DE69917809T patent/DE69917809T2/de not_active Expired - Lifetime
- 1999-03-01 PT PT99933301T patent/PT1156795E/pt unknown
- 1999-03-01 EP EP99933301A patent/EP1156795B1/de not_active Expired - Lifetime
- 1999-03-01 US US09/914,499 patent/US6521665B1/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
US6521665B1 (en) | 2003-02-18 |
EP1156795B1 (de) | 2004-06-02 |
DE69917809D1 (de) | 2004-07-08 |
ATE268170T1 (de) | 2004-06-15 |
AU4937499A (en) | 2000-09-21 |
WO2000051594A1 (en) | 2000-09-08 |
PT1156795E (pt) | 2004-09-30 |
ES2222717T3 (es) | 2005-02-01 |
DE69917809T2 (de) | 2004-11-04 |
CA2366073A1 (en) | 2000-09-08 |
EP1156795A1 (de) | 2001-11-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1539166T3 (da) | Farmaceutiske sammensætninger indeholdende dextromethorphan og quinidin til behandling af neurologiske sygdomme | |
DK1202736T3 (da) | Nikotin i terapeutisk angiogenese og vasculogenese | |
EA200401284A1 (ru) | Замещённые бензазолы и их применение в качестве ингибиторов киназы raf | |
CY1107467T1 (el) | Χρηση οξεογονων υδρογονοτροφων στελεχων για την προληψη ή την αγωγη πεπτικων διαταραχων | |
NO20064547L (no) | Fremgangsmater for behandling av HIV infeksjon | |
CY1105286T1 (el) | Ω-καρβοξυαρυλυποκατεστημενες διφαινυλουριες σαν αναστολεις της raf κινασης | |
DE60035870D1 (de) | Kombinationstherapie zur gewichtsreduzierung und fettleibigkeitsbehandlung | |
DK0950057T3 (da) | 3-pyridylenantiomerer og deres anvendelse som analgetika | |
ATE364595T1 (de) | Pyridoxin- und pyridoxalanaloga als cardiovasculäre therapeutika | |
BR0107628A (pt) | l,2-diarilbenzimidazóis para tratamento de doenças que estão associadas a uma ativação microglial | |
DK1228028T3 (da) | Hydroxyicosatetraenoatsalte, præparater og fremgangsmåder til anvendelse til behandling af öjentörhedslidelser | |
PT932613E (pt) | Expressao de bloqueio de factoes de virulencia em s. aureus | |
DK1082131T3 (da) | Immunoregulator | |
EE200300129A (et) | Distamütsiini alfa-halogenoakrüloüülderivaadi kasutamine | |
DK1156795T3 (da) | Anvendelse af ravsyre eller salte deraf, og fremgangsmåde til behandling af insulinresistens | |
DK0799618T3 (da) | Anvendelse af alpha1-adrenoreceptor-antagonister i fremstillingen af et medikament til forebyggelsen og behandlingen af cancer | |
NO940130D0 (no) | Benzimidazolderivater, fremgangsmaate for deres fremstilling og te rapeutisk anvendelse derav | |
NO984160L (no) | FremgangsmÕte for behandling eller forebyggelse av interstitiell cystitt | |
DK1073436T3 (da) | Forbedret fremgangsmåde til udryddelse af helicobacter pylori | |
NO20042138L (no) | Forbindelser og fremgangsmate for behandling av hyperaktiv blaere | |
DE60008590D1 (de) | Zusammensetzungen von adenosin a1 agonisten und cox2-hemmern | |
SE9904289D0 (sv) | Method and camposition for the treatment of adenovairal ocular infections | |
DK1227826T3 (da) | Sammensætninger omfattende et ekstrakt af Perna canaliculus, methylsulfonylmethan og glucosamid samt anvendelsen heraf | |
CY1109771T1 (el) | Η χρηση της φορμοτερολης στην προφυλακτικη και/ή θεραπευτικη αντιμετωπιση της μυικης απωλειας και/ή του καχεκτικου συνδρομου τα οποια συνδεονται με τις καταβολικες συνθηκες ορισμενων παθησεων. οπως ο καρκινος, to aids, οι μολυνσεις, ο διαβητης και αλλες | |
BRPI0408984A (pt) | método para tratar uma condição de doença mediada por células neutrofìlicas em um paciente, e, uso de um composto de ligação de histamina |